On September 30, 2025, Pulse Biosciences, Inc. held a special meeting where stockholders approved two proposals: adding 2 million shares to their Equity Incentive Plan and ratifying options for 600,000 shares to several directors. The approved options have an exercise price of $15.65 per share and will vest over time contingent on continued service.